↓ Skip to main content

Multicenter, single-arm, phase II study (CAP) of radiotherapy plus liposomal irinotecan followed by camrelizumab and anti-angiogenic treatment in advanced solid tumors

Overview of attention for article published in Frontiers in immunology, March 2023
Altmetric Badge

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
9 Mendeley